Physician profile
Mukesh Arora
NPI 1518975796
$11,421.66
in general payments reported to CMS, 2019-2025
42 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,928 · 2020: $891 · 2021: $2,604 · 2022: $3,001 · 2023: $898 · 2024: $940 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,996.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,926.89 | 2021-2025 | Vraylar |
| Novo Nordisk INC | $1,330.26 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $1,216.08 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $1,148.38 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $793.67 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $662.06 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $628.17 | 2019-2025 | Synjardy, Jardiance |
| Abbott Laboratories | $491.27 | 2020-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $425.93 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $305.58 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $252.27 | 2021-2025 | Spravato, Xarelto |
| Amgen INC. | $247.07 | 2019-2024 | Krystexxa |
| Boston Scientific Corporation | $218.17 | 2021-2025 | Watchman Access System |
| Exact Sciences Corporation | $213.78 | 2024-2025 | Cologuard Collection Kit |
| Merz North America, INC. | $180.24 | 2021-2023 | Xeomin |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mukesh Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.